Riskpilot← Back to searchSign inGet full accessApovac F.M.B.A.
FMAActiveCVR 40504044Smørmosevej 16CWholesale of pharmaceutical and medical goods · NACE 4646Est. 20194 employeeswww.apovac.dk
Revenue 2024
DKK 3M
-80% vs 2024
EBITDA margin
25.1%
-94% vs 2024
Equity ratio
87.6%
Financial strength
Net profit 2024
DKK -146K
-102% vs 2024
| Revenue | DKK 3M | -80% |
| EBITDA | DKK 763K | -94% |
| Net profit | DKK -146K | -102% |
| Total assets | DKK 13,9M | -35% |
| Equity | DKK 12,2M | -1% |
| Employees | 4 | — |
Legal name
Apovac F.M.B.A.
CVR number
40504044
Legal form
Forening med begrænset ansvar
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. april 2019
Share capital
—
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Foreningen tegnes af formanden i forening med direktøren, eller af næstformanden i forening med direktøren, eller af formanden og næstformanden i forening.
Company purpose
Foreningen en en erhvervsdrivende forening, der har til formål at fremme medlemmernes økonomiske interesser ved
1) at drive erhvervsmæssig virksomhed inden for vaccinationsområdet ved at sælge og markedsføre vaccinationsydelser, som formidles af medlemmerne på vegne af foreningen, og samt andre tilstødende aktiviteter på lignende vilkår, og
2) at yde medlemmerne bistand inden for vaccinationsområdet, herunder ved at tilvejebringe lægefaglig rådgivning og uddannelse til medlemmer samt indgå rammeaftaler med leverandører til brug for medlemmernes indkøb af vacciner samt andre tilstødende aktiviteter.
Address
Smørmosevej 16C
Phone
+4544223555
Email
apovac@apovac.dk
Website
www.apovac.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| Revenue | -1.746 | 10.871 | 2.019 | 14.968 | 3.043 |
| Staff expenses | -572 | -1.973 | -3.410 | -2.664 | -2.280 |
| EBITDA | -2.318 | 8.898 | -1.391 | 12.304 | 763 |
| Depreciation & amort. | -229 | -335 | -610 | -935 | -1.049 |
| EBIT | -2.547 | 8.563 | -2.001 | 11.370 | -286 |
| Net financials | -85 | -136 | -61 | -163 | 125 |
| Profit before tax | -2.631 | 8.427 | -2.061 | 11.207 | -161 |
| Tax | -0 | 656 | -376 | 2.471 | -16 |
| Net profit | -2.631 | 7.771 | -1.685 | 8.736 | -146 |
| Item | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2.208 | 9.065 | 7.094 | 21.470 | 13.874 |
| Equity | -2.845 | 5.028 | 3.425 | 12.251 | 12.157 |
| Long-term debt | 3.271 | 0 | 3.130 | 200 | 0 |
| Short-term debt | 1.782 | 3.989 | 539 | 8.198 | 934 |
| Total debt | 5.053 | 3.989 | 3.669 | 8.398 | 934 |
EBITDA margin
25.1%
This company
15.8%
Market median
+59% vs market
20212024
Equity ratio
87.6%
This company
38.2%
Market median
+129% vs market
20212024
Return on equity
-1.2%
This company
18.4%
Market median
-107% vs market
20212024
Net profit margin
-4.8%
This company
8.1%
Market median
-159% vs market
20212024
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20212024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-04-01 – 2024-12-31
- Annual report 2024Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TH Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (5) | ||
BK Management | Management | 2021 – 2022 |
NK Chief Executive Officer | Chief Executive Officer | 2023 – 2024 |
SH Management | Management | 2021 – 2021 |
KM Management | Management | 2021 – 2021 |
KJ Management | Management | 2019 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2025 | |
| Chairman | 2022 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Former (5) | ||
| Deputy Chairman | 2019 – 2022 | |
| Deputy Chairman | 2023 – 2025 | |
| Board of Directors | 2019 – 2022 | |
| Chairman | 2019 – 2022 | |
| Board of Directors | 2019 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Apovac F.M.B.A. also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tina Hoby Andersen | Chief Executive Officer | 0 companies |
| Bjarne Kalø | Management | 0 companies |
| Niels Kristensen | Chief Executive Officer | 0 companies |
| Søren Hellener | Management | 0 companies |
| Kristine Marcher Espersen | Management | 0 companies |
| Kristian Johnsen | Management | 0 companies |
| Lars Frode Nørgaard | Board of Directors | 0 companies |
| Tue Askaa | Deputy Chairman | 0 companies |
| Peter Aarenstrup Merrild | Board of Directors | 0 companies |
| Mikkel Rostgaard Jørgensen | Chairman | 0 companies |
| Gitte Andersen | Deputy Chairman | 0 companies |
| Jette Kristensen | Board of Directors | 0 companies |
| Peter Kim Høgh | Chairman | 0 companies |
| Per Wijngaard | Board of Directors | 0 companies |
| Vural Kocak | Board of Directors | 0 companies |
| Rikke Holm Løvaas | Board of Directors | 0 companies |